PURE Bioscience Share Price OTC Bulletin Board
Equities
US74621T2096
Household Products
Sales 2022 | 1.85M 155M | Sales 2023 | 1.88M 157M | Capitalization | 9.51M 793M |
---|---|---|---|---|---|
Net income 2022 | -3M -250M | Net income 2023 | -3M -250M | EV / Sales 2022 | 10.2 x |
Net cash position 2022 | 3.39M 283M | Net cash position 2023 | 74K 6.17M | EV / Sales 2023 | 5.03 x |
P/E ratio 2022 |
-5.08
x | P/E ratio 2023 |
-2.39
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 59.55% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Bartlett
CEO | Chief Executive Officer | 79 | 08/23/08 |
Mark Elliott
DFI | Director of Finance/CFO | 48 | 01/04/01 |
Dolana Blount
CTO | Chief Tech/Sci/R&D Officer | - | 01/98/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Bartlett
CEO | Chief Executive Officer | 79 | 08/23/08 |
Tom Myers
CTO | Chief Tech/Sci/R&D Officer | 71 | 09/11/09 |
Tom Lee
BRD | Director/Board Member | 75 | 24/14/24 |
1st Jan change | Capi. | |
---|---|---|
+9.64% | 25.35B | |
-4.29% | 16.95B | |
-14.45% | 7.05B | |
+4.25% | 5.88B | |
-8.13% | 2.98B | |
-3.86% | 2.15B | |
-5.73% | 1.9B | |
+22.51% | 914M | |
+4.92% | 663M |